Desisobutyryl ciclesonide
CAS: 161115-59-9
Ref. 3D-FD21205
| 1mg | Descatalogado | ||
| 2mg | Descatalogado | ||
| 5mg | Descatalogado | ||
| 10mg | Descatalogado | ||
| 25mg | Descatalogado |
Información del producto
Nombre:
Desisobutyryl ciclesonide
Sinónimos:
- (11b,16a)-16,17-[[(R)-Cyclohexylmethylene]bis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dioneCIC-APCiclesonide active principle
- CIC-AP
- Pregna-1,4-diene-3,20-dione, 16,17-[(cyclohexylmethylene)bis(oxy)]-11,21-dihydroxy-, [11β,16α(R)]-
- Ciclesonide active principle
- Pregna-1,4-diene-3,20-dione, 16,17-[[(R)-cyclohexylmethylene]bis(oxy)]-11,21-dihydroxy-, (11β,16α)-
- (11β,16α)-16,17-[[(R)-Cyclohexylmethylene]bis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
Descripción:
Desisobutyryl ciclesonide is a prodrug of ciclesonide, which is a potent and specific beta-adrenergic agonist. It has been shown to have a pharmacokinetic profile that is similar to the parent drug, with an elimination half-life of approximately six hours. Desisobutyryl ciclesonide is not metabolized by cytochrome P450 enzymes and has low oral bioavailability. The drug does not produce any significant adverse effects in animal studies when administered orally or intravenously.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
470.6 g/mol
Fórmula:
C28H38O6
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
